483 Shanghai Ambiopharm Aug 2013

483 Shanghai Ambiopharm Aug 2013

Michael Goga FDA$119.00 - Available Now

FDA investigators audited the Shanghai Ambiopharm - Shanghai, China facility and issued inspectional observations (via FDA 483) on 30 Aug 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Aug 2013
  • Location: Shanghai, China
  • FEI: 3006494603
Add To Cart